Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alexopoulos

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Plos Computational Biology|October 27, 2017
Dynamics and heterogeneity of brain damage in multiple sclerosisEkaterina Kotelnikova, Narsis A Kiani, Elena Abad, et al.
British Journal of Cancer|May 3, 2007
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working PartyT Berghmans, J J Lafitte, J Lecomte, et al.
Bioinformatics (Oxford, England)|October 9, 2014
A crowd-sourcing approach for the construction of species-specific cell signaling networksErhan Bilal, Theodore Sakellaropoulos, Ioannis N Melas, et al.
Genome Medicine|July 17, 2021
Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosisMarti Bernardo-Faura, Melanie Rinas, Jakob Wirbel, et al.
Frontiers in Cell and Developmental Biology|July 18, 2022
Immuno-Modulatory Effects of Intervertebral Disc CellsPaola Bermudez-Lekerika, Katherine B Crump, Sofia Tseranidou, et al.
Cell Systems|July 16, 2018
Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS SignalingOleksii S Rukhlenko, Fahimeh Khorsand, Aleksandar Krstic, et al.
Cell Death and Differentiation|August 28, 2021
Stress-induced inflammation evoked by immunogenic cell death is blunted by the IRE1α kinase inhibitor KIRA6 through HSP60 targetingNicole Rufo, Dimitris Korovesis, Sofie Van Eygen, et al.
The European Respiratory Journal|August 11, 2007
Chemotherapy improves low performance status lung cancer patientsJ P Sculier, J J Lafitte, M Paesmans, et al.
Redox Biology|March 6, 2018
Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insightsChristina Cheimonidi, Pinelopi Samara, Panagiotis Polychronopoulos, et al.
Molecular Systems Biology|February 18, 2026
Integrative multi-omics defines melanoma drug response networks and ARID1A-dependent resistance mechanismsCharlie George Barker, Sumana Sharma, Ana Mafalda Santos, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Plos Computational Biology|October 27, 2017
Dynamics and heterogeneity of brain damage in multiple sclerosisEkaterina Kotelnikova, Narsis A Kiani, Elena Abad, et al.
British Journal of Cancer|May 3, 2007
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working PartyT Berghmans, J J Lafitte, J Lecomte, et al.
Bioinformatics (Oxford, England)|October 9, 2014
A crowd-sourcing approach for the construction of species-specific cell signaling networksErhan Bilal, Theodore Sakellaropoulos, Ioannis N Melas, et al.
Genome Medicine|July 17, 2021
Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosisMarti Bernardo-Faura, Melanie Rinas, Jakob Wirbel, et al.
Frontiers in Cell and Developmental Biology|July 18, 2022
Immuno-Modulatory Effects of Intervertebral Disc CellsPaola Bermudez-Lekerika, Katherine B Crump, Sofia Tseranidou, et al.
Cell Systems|July 16, 2018
Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS SignalingOleksii S Rukhlenko, Fahimeh Khorsand, Aleksandar Krstic, et al.
Cell Death and Differentiation|August 28, 2021
Stress-induced inflammation evoked by immunogenic cell death is blunted by the IRE1α kinase inhibitor KIRA6 through HSP60 targetingNicole Rufo, Dimitris Korovesis, Sofie Van Eygen, et al.
The European Respiratory Journal|August 11, 2007
Chemotherapy improves low performance status lung cancer patientsJ P Sculier, J J Lafitte, M Paesmans, et al.
Redox Biology|March 6, 2018
Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insightsChristina Cheimonidi, Pinelopi Samara, Panagiotis Polychronopoulos, et al.
Molecular Systems Biology|February 18, 2026
Integrative multi-omics defines melanoma drug response networks and ARID1A-dependent resistance mechanismsCharlie George Barker, Sumana Sharma, Ana Mafalda Santos, et al.
Pageof 14